1 Guidance

1 Guidance

This guidance replaces the previous guidance on laparoscopic helium plasma coagulation for the treatment of endometriosis (Interventional Procedures Guidance no. 54, March 2004).

1.1 Current evidence suggests there are no major safety concerns associated with laparoscopic helium plasma coagulation for the treatment of endometriosis. However, evidence on efficacy does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research.

1.2 Clinicians wishing to undertake laparoscopic helium plasma coagulation for the treatment of endometriosis should take the following actions.

  • Inform the clinical governance leads in their Trusts.

  • Ensure that patients understand the uncertainty about the efficacy of the procedure and provide them with clear written information. In addition, use of the Institute's information for the public is recommended.

  • Audit and review clinical outcomes of all women undergoing laparoscopic helium plasma coagulation for the treatment of endometriosis.

1.3 Clinicians undertaking this procedure should have adequate training before performing the technique. The British Society for Gynaecological Endoscopy has produced standards for training.

1.4 Publication of randomised controlled trials on the efficacy of this procedure will be useful. The Institute may review the procedure upon publication of further evidence.